Madison, WI (PRWEB) February 27, 2014
Quincy Bioscience announces that its headquarters, shipping, and manufacturing locations have all been recertified as Good Manufacturing Practices (GMP) facilities registered by NSF International for 2014.
Earning GMP registration from NSF International verifies that Quincy Bioscience’s facilities have the proper methods, equipment, facilities, and controls in place for producing dietary supplement products. The NSF GMP’s were developed in accordance with the U.S. Food and Drug Administration’s (FDA) 21 CFR part 111 regulation on dietary supplement manufacturing, packaging, and distribution. Utilizing GMP guidelines assists companies in developing and maintaining proper controls in their manufacturing process so that products are processed, manufactured and labeled in a consistent manner, and meet quality standards.
“We’re proud to maintain this important recognition for all of our locations,” said Mark Underwood, President and co-founder of Quincy Bioscience. “We take good manufacturing practices very seriously in every department of our organization and we’re pleased that NSF continues to acknowledge our practice of excellence.”
Prevagen®, the No. 1 selling brain health supplement in chain drug pharmacies, is manufactured at the NSF registered facility. Prevagen is available in 25,000 stores across the country.
Please visit http://www.quincybioscience.com for more information.
About Quincy Bioscience:
Quincy Bioscience is a biotechnology company based in Madison, Wis. that focuses on the discovery, development and commercialization of novel technologies to support good health in aging. The company’s products focus on supporting memory and cognitive health. Quincy Bioscience is set apart by its cutting-edge applications of the protein apoaequorin, which is breaking new ground in the area of brain health.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.